These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20023594)

  • 1. Bisphosphonates pathway.
    Gong L; Altman RB; Klein TE
    Pharmacogenet Genomics; 2011 Jan; 21(1):50-3. PubMed ID: 20023594
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term use of bisphosphonates in osteoporosis.
    Watts NB; Diab DL
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonate treatment of osteoporosis and other skeletal diseases].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2011 Feb; 131(3):244-7. PubMed ID: 21304573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis].
    Tanaka M; Mori H; Shimizu K; Toshiyuki ; Matsuoka ; Yamamotoya H; Minamide T; Mori M; Nozaki K; Usui T; Shimokawa K; Suzuki H; Aoyama K; Kimoto A; Sasamata M; Miyata K
    Nihon Yakurigaku Zasshi; 2009 Sep; 134(3):149-57. PubMed ID: 19749488
    [No Abstract]   [Full Text] [Related]  

  • 5. [When should bisphosphonate treatment be discontinued?].
    Eriksen EF; Halse J
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1630-2. PubMed ID: 22875131
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonates: how do they work?
    Papapoulos SE
    Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):831-47. PubMed ID: 19028359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibandronate in profile: drug characteristics and clinical efficacy.
    Reginster JY; Neuprez A; Bruyère O
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):941-51. PubMed ID: 18624681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid: a review of its use in the treatment of osteoporosis.
    Deeks ED; Perry CM
    Drugs Aging; 2008; 25(11):963-86. PubMed ID: 18947264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for osteoporosis--where do we go from here?
    Whitaker M; Guo J; Kehoe T; Benson G
    N Engl J Med; 2012 May; 366(22):2048-51. PubMed ID: 22571168
    [No Abstract]   [Full Text] [Related]  

  • 10. Bisphosphonates for osteoporosis: benefits and risks.
    Bollerslev J; Harris ST; Leder BZ
    J Clin Endocrinol Metab; 2011 Sep; 96(9):27A, 28A. PubMed ID: 21896893
    [No Abstract]   [Full Text] [Related]  

  • 11. Should bisphosphonates be used in premenopausal women?
    Cohen A
    Maturitas; 2010 May; 66(1):3-4. PubMed ID: 20356692
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefits and risks of bisphosphonate therapy for osteoporosis.
    Khosla S; Bilezikian JP; Dempster DW; Lewiecki EM; Miller PD; Neer RM; Recker RR; Shane E; Shoback D; Potts JT
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2272-82. PubMed ID: 22523337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates: AHFS 92:24.
    Toller CS; Charlesworth S; Mihalyo M; Howard P; Wilcock A
    J Pain Symptom Manage; 2019 May; 57(5):1018-1030. PubMed ID: 30738144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to use bisphosphonates safely and optimally.
    Jagpal A; Saag KG
    Rheumatology (Oxford); 2018 Nov; 57(11):1875-1876. PubMed ID: 29165674
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E; Sheehy C; Barry M; Carey J
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bisphosphonate].
    Hagino H
    Nihon Rinsho; 2011 Jul; 69(7):1253-7. PubMed ID: 21774367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates. A cornerstone of osteoporosis treatment.
    Mayo Clin Womens Healthsource; 2007 May; 11(5):1-2. PubMed ID: 17476171
    [No Abstract]   [Full Text] [Related]  

  • 19. Minodronate for the treatment of osteoporosis.
    Kubo T; Shimose S; Matsuo T; Fujimori J; Ochi M
    Drugs Today (Barc); 2010 Jan; 46(1):33-7. PubMed ID: 20200694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A query from medical practice: the biological half-life of biphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2008 Dec; 133(51-52):2700-1. PubMed ID: 19067274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.